Coastal Bridge Advisors LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% during the second quarter, Holdings Channel.com reports. The firm owned 843 shares of the healthcare conglomerate’s stock after buying an additional 32 shares during the period. Coastal Bridge Advisors LLC’s holdings in UnitedHealth Group were worth $338,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. OLD Mission Capital LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $439,000. Camden National Bank lifted its position in UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after acquiring an additional 100 shares during the last quarter. Signet Financial Management LLC purchased a new stake in UnitedHealth Group during the first quarter valued at approximately $277,000. Unigestion Holding SA lifted its position in UnitedHealth Group by 52.6% during the first quarter. Unigestion Holding SA now owns 1,778 shares of the healthcare conglomerate’s stock valued at $662,000 after acquiring an additional 613 shares during the last quarter. Finally, Avidian Wealth Solutions LLC lifted its position in UnitedHealth Group by 9.6% during the first quarter. Avidian Wealth Solutions LLC now owns 1,801 shares of the healthcare conglomerate’s stock valued at $670,000 after acquiring an additional 158 shares during the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.
UNH stock traded up $8.85 during midday trading on Wednesday, hitting $421.39. 100,771 shares of the stock traded hands, compared to its average volume of 2,983,495. The firm has a market cap of $397.34 billion, a P/E ratio of 27.25, a PEG ratio of 1.62 and a beta of 0.77. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.77 and a quick ratio of 0.77. The stock’s fifty day simple moving average is $416.16 and its 200-day simple moving average is $398.29. UnitedHealth Group Incorporated has a 1-year low of $289.64 and a 1-year high of $431.36.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 21st. Stockholders of record on Monday, September 13th will be given a $1.45 dividend. The ex-dividend date is Friday, September 10th. This represents a $5.80 annualized dividend and a dividend yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.36%.
A number of research analysts have issued reports on UNH shares. Bank of America raised their price target on shares of UnitedHealth Group from $450.00 to $522.00 and gave the stock a “buy” rating in a report on Tuesday, June 1st. Cowen started coverage on shares of UnitedHealth Group in a report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price target for the company. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $418.00 to $421.00 and gave the stock a “buy” rating in a report on Tuesday, July 13th. Raymond James raised their price target on shares of UnitedHealth Group from $435.00 to $515.00 and gave the stock a “strong-buy” rating in a report on Friday, July 16th. Finally, Seaport Global Securities began coverage on shares of UnitedHealth Group in a report on Friday, July 9th. They issued a “buy” rating and a $450.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $444.04.
In other news, Director Stephen J. Hemsley sold 60,000 shares of the business’s stock in a transaction that occurred on Friday, July 16th. The shares were sold at an average price of $420.62, for a total value of $25,237,200.00. Following the sale, the director now directly owns 941,560 shares of the company’s stock, valued at approximately $396,038,967.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John F. Rex sold 15,438 shares of the business’s stock in a transaction that occurred on Thursday, July 29th. The shares were sold at an average price of $412.04, for a total transaction of $6,361,073.52. The disclosure for this sale can be found here. Insiders have sold 100,438 shares of company stock worth $41,902,034 over the last 90 days. 0.55% of the stock is currently owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Story: What is the S&P/ASX 200 Index?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.